That's interesting. It was recommended (at another NCI center) that I take it along with Orgovyx for 2 years to align with the STAMPEDE trial results. I wonder if Mayo's MOs have some clinical data that suggests there are benefits to continuing it another 6 months? I assume we're talking about cases of locally advanced and not distant metastatic PCa.